In gastric cancer, patients with higher UBE2C expression levels also had shorter OS (log-rank p = 0.033) and time to first progression(FP; log-rank p < 0.001) but better PPS(log-rank p < 0.001) (Figure 3B). This evidence concerns the gene UBE2C and gastric cancer.